Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Fructo-oligosaccharides (1-Kestose).
Fructo-oligosaccharides function as non-digestible prebiotic fibers that selectively stimulate the proliferation of bifidobacteria and lactobacilli in the colon, thereby modulating the gut-brain axis and enhancing mineral absorption through the production of short-chain fatty acids.
439653
329.4 g/mol
3
(1S)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Fructo-oligosaccharides (1-Kestose) across standard consumer modalities.
High hygroscopicity and low bulk density require large capsule sizes to achieve clinically relevant prebiotic dosages, often leading to poor patient compliance.
FOS acts as a functional bulking agent and humectant in pectin matrices, but excessive concentrations can interfere with gel strength and lead to a sticky, unstable texture.
The high effective dose required for prebiotic activity far exceeds the physical payload capacity of thin-film polymer matrices, making this format impractical for FOS.
Ready to launch a product featuring Fructo-oligosaccharides (1-Kestose)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Fructo-oligosaccharides (1-Kestose) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Fructo-oligosaccharides (1-Kestose) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation